Skip to content
Toggle navigation
Home
About MS
Toggle menu
Multiple sclerosis overview
Types of MS
Causes and risk factors
Symptoms
Diagnosis
Living with MS
Treatments options for MS
Approved treatments
Experimental treatments
Clinical Trials
What are clinical trials?
Types of clinical trials
How do clinical trials work?
Traditional vs. remote vs. hybrid clinical trials
FAQs about clinical trials
Featured Topics
Toggle menu
Newly diagnosed guide
Next steps after an MS diagnosis
MS caregivers guide
MS healthcare team
Perspectives on MS diagnosis
MS treatment explainer
Questions to ask your doctor
Guidelines for MS diagnosis
Physical activity and quality of life
Foods to eat and avoid
Vitamin D and MS
Support and resources
MS and spasticity
View all
Expert voices
Exercise
Pain management
Cannabis use
Diet and nutrition
Financial planning
Managing fatigue
Sleeping well
More
Resources
MS hug
MS and heat
Cannabis and MS
Lesions and MS
Myelin's role in MS
Epstein-Barr virus and MS
Stem cell therapy for MS
MS prognosis and life expectancy
MS and mental health
News
Columns
Toggle menu
Authentically Human
ā Desiree Lama
Balancing Grit and Grace
ā Ahna Crum
Chairborne
ā Ben Hofmeister
Delicate Balance
ā Leigh Anne Nelson
Rhythms and Routines
ā Susan Payrovi, MD
Archived Columns
A Life in Letters
ā Jamie Hughes
DISabled to ENabled
ā Jessie Ace
Dive to Fight MS
ā Mike Parker
Fall Down, Get Up Again
ā John Connor
Goldilochs
ā Stephen De Marzo
Patiently Awakened
ā Teresa Wright-Johnson
The MS Wire
ā Ed Tobias
Silver Linings
ā Jennifer Powell
In memoriam
Through the Looking Glass
ā Beth Shorthouse-Ullah
Forums
Podcast
Search
Close drawer
What can we help you find today?
Search for:
Search
Search
Search for:
Search
trelarosa, —
Articles by
Recent Posts
1-year fenebrutinib curbs nearly all disease activity in relapsing MS trial
Rituximab treatment stabilizes disability in SPMS patients: Analysis
MS and bowel incontinence definitely do ‘break my stride’
Envelope icon
Subscribe to our newsletter
Get regular updates to your inbox.
Your Email
Subscribe
Leave this field empty if you're human:
We use cookies
to enhance your experience on our website.
Privacy Policy
Accept